Go Pro
→ A 50-year dollar arrangement just ended - what it means for you (From Golden Portfolio) (Ad)tc pixel Free CGEM Stock Alerts

Cullinan Therapeutics (CGEM) Short Interest Ratio & Short Volume

Cullinan Therapeutics logo
$17.22 -0.21 (-1.20%)
As of 11:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Cullinan Therapeutics Short Interest Overview

As of July 15, 2026, Cullinan Therapeutics (CGEM) had a short interest of 10.29 million shares sold short, representing 18.31% of the public float. This marks a -2.94% decrease in short interest since the prior report. The short interest ratio (days to cover) is 15.2, meaning it would take 15.2 days of the average trading volume of 890,545 shares to cover all short positions.

Current Short Interest
10,285,963 shares
Previous Short Interest
10,597,500 shares
Change Vs. Previous Month
-2.94%
Dollar Volume Sold Short
$183.40 million
Short Interest Ratio
15.2 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
61,458,000 shares
Short Percent of Float
18.31%
Today's Trading Volume
148,894 shares
Average Trading Volume
890,545 shares
Today's Volume Vs. Average
17%
Short Selling Cullinan Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Cullinan Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CGEM Short Interest Over Time

CGEM Days to Cover Over Time

CGEM Percentage of Float Shorted Over Time

Cullinan Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202610,285,963 shares $183.40 million -2.9%18.3%15.22 $17.83
6/30/202610,597,500 shares $192.98 million +29.5%18.9%6.62 $18.21
6/15/20268,185,218 shares $111.40 million +2.7%14.6%6.29 $13.61
5/29/20267,973,648 shares $131.09 million -8.1%14.2%7.05 $16.44
5/15/20268,680,186 shares $136.54 million -1.4%15.5%8.19 $15.73
4/30/20268,799,071 shares $114.83 million +8.4%15.7%15.27 $13.05
4/15/20268,114,946 shares $121.32 million -3.3%14.4%10.56 $14.95
3/31/20268,394,357 shares $119.28 million +0.4%14.9%9.32 $14.21
3/13/20268,364,143 shares $112.83 million +3.5%14.9%10.63 $13.49
2/27/20268,080,892 shares $125.25 million +0.8%14.4%8.96 $15.50
2/13/20268,015,222 shares $92.90 million +0.5%14.3%11.67 $11.59
1/30/20267,976,684 shares $95.40 million -5.3%14.2%12 $11.96
1/15/20268,421,475 shares $89.77 million +3.5%15.0%12.18 $10.66
12/31/20258,136,316 shares $84.21 million +19.3%14.5%7.73 $10.35
12/15/20256,821,318 shares $73.81 million -0.8%12.1%5.34 $10.82
11/28/20256,876,864 shares $78.19 million +3.0%12.2%4.09 $11.37
11/14/20256,678,836 shares $57.10 million +2.6%12.0%9.63 $8.55
10/31/20256,509,523 shares $56.37 million -1.8%11.7%6 $8.66
10/15/20256,630,000 shares $57.22 million +8.7%18.0%8.1 $8.63
9/30/20256,100,000 shares $36.17 million -1.3%16.8%9.6 $5.93
9/15/20256,180,000 shares $39.24 million -1.0%17.0%14 $6.35
8/31/20256,240,000 shares $47.05 million +6.7%17.2%16.1 $7.54
8/15/20255,850,000 shares $44.81 million -9.3%16.1%16.6 $7.66
7/31/20256,450,000 shares $50.12 million +9.7%17.8%17.6 $7.77
7/15/20255,880,000 shares $43.81 million -1.8%16.4%15.6 $7.45
6/30/20255,990,000 shares $45.10 million +0.5%16.7%14.1 $7.53
6/15/20255,960,000 shares $51.32 million -3.6%16.6%13.9 $8.61
5/31/20256,180,000 shares $53.52 million +3.2%17.2%13.7 $8.66
5/15/20255,990,000 shares $43.37 million -19.9%16.7%13 $7.24
4/30/20257,480,000 shares $61.93 million -6.4%20.9%16.2 $8.28
4/15/20257,990,000 shares $62.32 million -6.3%22.5%17.3 $7.80
3/31/20258,530,000 shares $64.57 million -1.6%24.1%18.1 $7.57
3/15/20258,670,000 shares $76.21 million +0.1%24.4%17.7 $8.79
2/28/20258,660,000 shares $73.52 million -1.3%24.4%17.4 $8.49
2/15/20258,770,000 shares $83.58 million +0.5%24.6%17.2 $9.53
1/31/20258,730,000 shares $92.19 million -10.7%23.7%15.7 $10.56
1/15/20259,780,000 shares $99.56 million -0.4%26.6%18.4 $10.18
12/31/20249,820,000 shares $119.61 million +1.8%26.7%19 $12.18
12/15/20249,650,000 shares $113.39 million +5.4%26.0%19.5 $11.75
11/30/20249,160,000 shares $123.20 million +5.2%24.7%16.8 $13.45
Do this before December or regret it (Ad)

Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel

Watch Porter Stansberry's full briefing and get his three steps to prepare before December.
11/15/20248,710,000 shares $120.72 million -3.4%23.5%16.2 $13.86
10/31/20249,020,000 shares $140.26 million -0.4%23.0%17.1 $15.55
10/15/20249,060,000 shares $147.13 million -1.6%23.2%15.7 $16.24
9/30/20249,210,000 shares $154.18 million +9.4%23.6%14.2 $16.74
9/15/20248,420,000 shares $151.14 million +4.6%21.6%11.7 $17.95
8/31/20248,050,000 shares $157.78 million -1.4%20.9%10.2 $19.60
8/15/20248,160,000 shares $137.99 million -2.4%21.2%10.3 $16.91
7/31/20248,360,000 shares $161.77 million +6.0%20.6%10 $19.35
7/15/20247,890,000 shares $130.90 million +0.6%19.4%8 $16.59
6/30/20247,840,000 shares $136.73 million +73.5%19.3%8 $17.44
6/15/20244,520,000 shares $85.34 million +4.2%10.3%5.1 $18.88
5/31/20244,340,000 shares $101.99 million +16.0%11.0%5.5 $23.50
5/15/20243,740,000 shares $99.93 million +58.5%11.9%5 $26.72
4/30/20242,360,000 shares $63.74 million +40.5%10.2%3.3 $27.01
4/15/20241,680,000 shares $27.80 million +16.7%6.4%3.1 $16.55
3/31/20241,440,000 shares $24.54 million +53.9%5.5%3.4 $17.04
3/15/2024935,400 shares $14.90 million +34.8%3.6%2.3 $15.93
2/29/2024694,100 shares $12.82 million -11.5%2.6%1.8 $18.47
2/15/2024783,900 shares $14.45 million -46.7%2.9%2.3 $18.43
1/31/20241,470,000 shares $22.26 million +34.9%5.4%5.1 $15.14
1/15/20241,090,000 shares $11.54 million +3.8%4.0%5.2 $10.59
12/31/20231,050,000 shares $10.70 million -48.5%3.9%5.4 $10.19
12/15/20232,040,000 shares $16.81 million -3.3%7.5%11.1 $8.24
11/30/20232,110,000 shares $17.28 million -2.3%7.8%12.5 $8.19
11/15/20232,160,000 shares $19.16 million +0.5%8.0%13.3 $8.87
10/31/20232,150,000 shares $20.06 million -1.8%7.9%12.9 $9.33
10/15/20232,190,000 shares $19.27 million -0.5%8.1%12.9 $8.80
9/30/20232,200,000 shares $19.91 million +0.9%8.1%12.1 $9.05
9/15/20232,180,000 shares $21.71 million -17.7%8.0%11.5 $9.96
8/31/20232,650,000 shares $27.43 million +33.2%9.8%10.2 $10.35
8/15/20231,990,000 shares $20.32 million +2.6%7.4%6.4 $10.21
7/31/20231,940,000 shares $20.54 million -18.5%8.2%6.1 $10.59
7/15/20232,380,000 shares $27.89 million +15.5%10.1%7.6 $11.72
6/30/20232,060,000 shares $22.17 million -11.6%8.7%6.8 $10.76
6/15/20232,330,000 shares $29.59 million +2.6%9.9%7.6 $12.70
5/31/20232,270,000 shares $23.34 million +0.9%9.6%8.6 $10.28
5/15/20232,250,000 shares $22.37 million +0.5%9.5%10.7 $9.94
4/30/20232,240,000 shares $21.80 million +0.5%9.5%10.7 $9.73
4/15/20232,230,000 shares $22.34 million +0.5%9.5%9.9 $10.02
3/31/20232,220,000 shares $22.71 million +1.8%9.4%10.2 $10.23
3/15/20232,180,000 shares $24.44 million +3.8%7.7%10.5 $11.21
2/28/20232,100,000 shares $23.71 million +1.5%7.0%13.3 $11.29
2/15/20232,070,000 shares $23.91 million +6.7%6.9%13.7 $11.55
1/31/20231,940,000 shares $22.58 million -9.4%6.6%13.7 $11.64
1/15/20232,140,000 shares $23.50 million -1.8%7.2%16.4 $10.98
12/30/20222,180,000 shares $23.00 million No Change7.4%17 $10.55
12/15/20222,180,000 shares $24.96 million No Change7.4%15.9 $11.45
11/30/20222,180,000 shares $27.10 million -5.6%7.4%14.8 $12.43
11/15/20222,310,000 shares $29.48 million -4.9%8.0%14.2 $12.76
10/31/20222,430,000 shares $31.93 million -0.4%8.5%15.4 $13.14
60 years. Zero competitors. (Ad)

One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 times global electricity demand - with zero competition. Last year, their crew drilled in 16 days what the government projected would take 64. Now Google has a 15-year deal locked in, Bill Gates has committed $100 million, and the Pentagon has made it a top priority. On August 18th, a new Washington policy adds another advantage rivals cannot match.tc pixel

See the full story behind the 60-year energy monopoly
10/15/20222,440,000 shares $30.79 million -1.2%8.5%15.7 $12.62
9/30/20222,470,000 shares $31.67 million +14.4%8.6%14.2 $12.82
9/15/20222,160,000 shares $28.21 million -13.6%7.5%10.9 $13.06
8/31/20222,500,000 shares $33.70 million No Change8.8%10.5 $13.48
8/15/20222,500,000 shares $35.40 million +2.9%8.8%8.5 $14.16
7/31/20222,430,000 shares $32.83 million -17.9%9.9%4.1 $13.51
7/15/20222,960,000 shares $43.57 million -1.7%12.1%4.9 $14.72
6/30/20223,010,000 shares $38.59 million -0.7%12.3%5.2 $12.82
6/15/20223,030,000 shares $36.09 million +6.3%12.4%5.2 $11.91
5/31/20222,850,000 shares $30.47 million +4.0%11.7%5.3 $10.69
5/15/20222,740,000 shares $29.10 million +3.8%11.2%5.7 $10.62
4/30/20222,640,000 shares $25.90 million +7.8%11.2%14.4 $9.81
4/15/20222,450,000 shares $27.44 million -3.5%10.4%13.2 $11.20
3/31/20222,540,000 shares $26.59 million -7.3%11.0%13.3 $10.47
3/15/20222,740,000 shares $34.91 million +1.5%12.1%13.2 $12.74
2/28/20222,700,000 shares $38.72 million +5.9%12.0%10.3 $14.34
2/15/20222,550,000 shares $37.69 million -3.4%11.3%9.6 $14.78
1/31/20222,640,000 shares $35.59 million -13.7%12.1%9.9 $13.48
1/15/20223,060,000 shares $41.89 million -1.0%13.4%11.4 $13.69
12/31/20213,090,000 shares $47.68 million +27.2%14.3%10.7 $15.43
12/15/20212,430,000 shares $38.71 million +3.4%11.2%9.4 $15.93
11/30/20212,350,000 shares $42.30 million -0.8%10.9%9.9 $18.00
11/15/20212,370,000 shares $49.68 million -7.8%8.1%9.3 $20.96
10/29/20212,570,000 shares $57.11 million +0.8%8.9%10.3 $22.22
10/15/20212,550,000 shares $63.75 million -1.9%8.8%10.6 $25.00
9/30/20212,600,000 shares $58.68 million +42.9%9.0%11.7 $22.57
9/15/20211,820,000 shares $52.78 million -24.5%6.3%7.6 $29.00
8/31/20212,410,000 shares $68.01 million -11.1%8.4%11.7 $28.22
8/13/20212,710,000 shares $75.09 million No Change9.5%12.4 $27.71

CGEM Short Interest - Frequently Asked Questions

Short interest is the volume of Cullinan Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 10,285,963 shares of CGEM short. 18.31% of Cullinan Therapeutics' shares are currently sold short. Learn More on Cullinan Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEM shares currently have a short interest ratio of 15.2. Learn More on Cullinan Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.31% of Cullinan Therapeutics' floating shares are currently sold short.

Cullinan Therapeutics saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 10,285,963 shares, a drop of 2.9% from the previous total of 10,597,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.31% of Cullinan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cullinan Therapeutics: Legend Biotech Corporation Sponsored ADR (7.58%), Viking Therapeutics, Inc. (21.06%), ACADIA Pharmaceuticals Inc. (8.73%), Edgewise Therapeutics, Inc. (11.90%), Tango Therapeutics, Inc. (31.59%), Dyne Therapeutics, Inc. (14.36%), Catalyst Pharmaceuticals, Inc. (0.31%), Relay Therapeutics, Inc. (23.39%), Denali Therapeutics Inc. (11.19%), Alumis Inc. (8.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling CGEM is an investing strategy that aims to generate trading profit from Cullinan Therapeutics as its price is falling. CGEM shares are trading up $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cullinan Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEM, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CGEM:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:CGEM) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
A 50-year dollar arrangement just ended - what it means for you
In 1974, Henry Kissinger helped create the U.S.-Saudi Arabia Joint Commission on Economic Cooperation - a litt...
Golden Portfolio | Sponsoredtc pixel
How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts
JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...
Golden Crest Metals | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
What Elon told his top shareholders in Texas
Late last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...
Banyan Hill Publishing | Sponsoredtc pixel